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We sequenced the genomes of 3,615 strains of serotype Emm
protein 1 (M1) group A Streptococcus to unravel the nature and
timing of molecular events contributing to the emergence, dissem-
ination, and genetic diversification of an unusually virulent clone
that now causes epidemic human infections worldwide. We dis-
covered that the contemporary epidemic clone emerged in stepwise
fashion from a precursor cell that first contained the phage encoding
an extracellular DNase virulence factor (streptococcal DNase D2,
SdaD2) and subsequently acquired the phage encoding the SpeA1
variant of the streptococcal pyrogenic exotoxin A superantigen. The
SpeA2 toxin variant evolved from SpeA1 by a single-nucleotide
change in the M1 progenitor strain before acquisition by horizon-
tal gene transfer of a large chromosomal region encoding secreted
toxins NAD+-glycohydrolase and streptolysin O. Acquisition of this
36-kb region in the early 1980s into just one cell containing the
phage-encoded sdaD2 and speA2 genes was the final major molecu-
lar event preceding the emergence and rapid intercontinental spread
of the contemporary epidemic clone. Thus, we resolve a decades-old
controversy about the type and sequence of genomic alterations that
produced this explosive epidemic. Analysis of comprehensive, popu-
lation-based contemporary invasive strains from seven countries
identified strong patterns of temporal population structure. Com-
paredwith a preepidemic reference strain, the contemporary clone is
significantly more virulent in nonhuman primate models of pharyn-
gitis and necrotizing fasciitis. A key finding is that the molecular
evolutionary events transpiring in just one bacterial cell ultimately
have produced millions of human infections worldwide.
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Understanding of the nature and timing of many criticalmolecular events underlying emergence and dissemination
of microbial pathogens that cause epidemic disease remains
elusive. Comprehensive delineation of the key molecular con-
tributors to these processes is essential for developing better
strategies to recognize and predict virulent strain emergence and
epidemics, formulate protective public health policies and maneu-
vers, and develop or modify vaccines. In recent years, fast and
inexpensive massively parallel DNA sequencing has facilitated
genetically based enhanced understanding of these and other in-
fectious disease problems.
Group A Streptococcus (GAS, also known as Streptococcus
pyogenes), a Gram-positive bacterial pathogen, causes human
infections worldwide (1–20). For example, GAS is responsible
for more than 600 million infections globally each year, including
a conservative estimate of 10,000–15,000 severe invasive infec-
tions annually in the United States (4). This organism has a long-
recognized proclivity to cause epidemic waves, the reasons for
which are largely unknown. After several decades of declining
incidence, a striking resurgence of severe invasive infections
caused by serotype Emm protein 1 (M1) GAS was reported in
many countries in the late 1980s and early 1990s (1–3, 5–20). The
resurgence received widespread public interest in part because of
the untimely death of Jim Henson, the Muppeteer, of invasive
GAS, and because of severe infections occurring in other notable
public figures in Canada and elsewhere (21). This resurgence of
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severe life-threatening GAS infections was a potent reminder that
we know relatively little about the evolutionary genetic events and
epidemiological forces that underpin temporal variation in bacte-
rial disease frequency and severity. Lack of precise understanding
of these topics significantly hobbles our ability to understand and
predict bacterial strain emergence and epidemics.
GAS serves as a model pathogen for studying the evolutionary
genomics of epidemic disease in part because it causes abundant
human infections; comprehensive, population-based strain col-
lections are available from diverse countries; the organism has
a relatively small genome size (∼1.8 Mb); and high-quality full-
genome sequences are available for strains of diverse M protein
serotypes (22, 23). In addition, humans are the pathogen’s only
natural host, which means that genetic and epidemiologic events
are not obscured by processes occurring in nonhuman hosts or
the environment. The primary goal of this study was to test the
hypothesis that large-scale genome sequencing and animal in-
fection models would shed new light on heretofore vague molec-
ular events contributing to the evolutionary genomics of epidemic
disease in general, and specifically in GAS. Our findings are
based on the largest bacterial whole-genome sequencing project
reported thus far.
Results and Discussion
Genome-Wide Polymorphism Levels and Genes with Evidence of
Diversifying Selection. We studied 3,615 serotype M1 organisms
from diverse locations on two continents (Table 1, Dataset S1, and
Fig. S1). Most of the strains were collected as part of compre-
hensive, population-based studies conducted in the areas sampled.
To determine the genome-wide polymorphisms present in these
3,615 strains, we first resequenced the genome of reference se-
rotype M1 strains SF370 (23) and MGAS5005 (24), using Illu-
mina-based technology. Although each of these genomes had
been sequenced initially to high quality (Q40 consensus), using
technology available at the time (Sanger dideoxy terminator se-
quencing), resequencing to ∼125-fold coverage permitted us to
correct a total of 235 errors in the genome assemblies (180 for
SF370 and 55 for MGAS5005). The previously deposited genome
sequences have been updated.
Comparison of the two corrected core genomes using a com-
bination of bioinformatics analyses [variant ascertainment algo-
rithm (VAAL), MUMmer, and ClustalW; see SI Materials and
Methods], and targeted Sanger sequencing revealed that these
two strains differed by 933 polymorphisms, including 896 SNPs
and 37 indels. Approximately two-thirds of these polymorphisms
(n = 576/896 SNPs) are located in a contiguous 36-kb region of the
genome we previously described (24); the remaining one-third of
polymorphisms (n = 320/896 SNPs) are distributed throughout
the core genome [i.e., the ∼1.7-Mb portion of the chromosome
common among GAS serotypes that remains after exclusion of
mobile genetic elements (MGEs)]. One-half of the polymorphisms
(n = 286/576) in this 36-kb region are concentrated in a highly
divergent 2.6-kb region between the slo and metB genes (Fig. 1).
Analysis of the 3,615 genome sequences, using VAAL, iden-
tified 13,221 SNP loci (3,727 synonymous, 7,609 nonsynonymous,
and 1,982 intergenic SNPs) and 1,598 indels (1,027 in coding
sequences and 571 in intergenic regions) in the core genome.
Inference of genetic relationships based on the core genome
SNPs divided the strains into two subpopulations that mirrored
the region of recombination group designation, including 172
strains that are SF370-like and 3,443 strains that are MGAS5005-
like (Fig. 2A). Excluding the horizontally acquired polymorphisms
in the 36-kb region of recombination, all 3,615 organisms are
closely related genetically (Fig. 2B), differing strain-to-strain on
average by only 48 SNPs and 8 indels distributed throughout the
core genome. The average genetic distance between strains of
the postresurgence MGAS5005-like population and strains of
the preresurgence SF370-like population is 113 core-genome
SNPs. The postresurgence strains differ, on average, by only 41
SNPs and 7 indels in the core genome, whereas the preresurgence
strains differ, on average, by 104 SNPs and 15 indels in the core
genome. Five genes that encode known virulence factors and are
likely under positive selection had levels of allelic variation sig-
nificantly greater than average: M protein (emm), regulator of
protease B (ropB), streptococcal inhibitor of complement (sic),
and the two-component-system control of virulence regulator
(covR) and sensor (covS).
Variation in MGE Content. Prophages and integrative conjugative
elements (ICEs) are critical actors in pathogen–host interactions
because in many bacteria (including GAS), they encode one or
more virulence factor or factors mediating resistance to antimi-
crobial agents. Most genomes of GAS are polylysogenic and
generally contain 3 or more distinct prophages and one or more
Table 1. Summary of 3,615 strains studied
Geographic region Time span Number of strains
Ontario, Canada 1996–2009 346
Denmark 1973–2013 436
East Germany 1969–1991 155
Finland 1988–2011 1106
Iceland 1988–2010 50
Norway 1997–2009 215
Sweden 1973–2012 482
Georgia, USA 1995–2010 340
Minnesota, USA 1997–2010 474
Other ∼1920s–1980s 11
Information for the complete list of 3,615 strains is found in Dataset S1.
Fig. S1 contains specific years included in the study. East Germany refers to
the former East Germany. Canada strains were from Ontario. US strains were
from Georgia (Atlanta area) and Minnesota. “Other” includes strains of pre-
dominantly historic interest.
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Fig. 1. Comparison of SNP distribution in strain SF370 and strain MGAS5005.
Polymorphisms between the SF370 and MGAS5005 genomes were identified
using a combination of sequence alignment and polymorphism discovery
tools: VAAL, MUMmer, and ClustalX. (A) Distribution of SNPs across the
MGAS5005 genome. Plotted is the SNP density (y axis) in a 5-kb window
iterated every 100 bp across the MGAS5005 genome (x-axis). The distribution
of SNPs is nonrandom, with 576 (64.3%) of 896 SNPs occurring in the 36-kb
region between the purA and nadC genes. (B) Distribution of SNPs across the
MGAS5005 genome 36-kb region of recombination. Plotted is the SNP density
in a 100-bp window iterated every 50 bp across the 36-kb region of recom-
bination. The distribution of SNPs is nonrandom, with 286 (49.7%) of 586 SNPs
occurring in the 2.6-kb sequence between the slo and metB genes.
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ICEs (25). Common GAS prophage-encoded virulence factors
include pyrogenic toxin superantigens, extracellular DNases,
and a secreted phospholipase A2 (22–33). GAS ICE-encoded
antimicrobial agents typically include those mediating resistance
to tetracycline or macrolides (34).
To assess variation in MGE content in the strain samples
studied here, we used a two-step process. First, to detect loss of
known M1 gene content, sequence reads for each strain were
mapped to the MGAS5005 and/or SF370 reference genomes.
Second, to detect gain of known GAS gene content not repre-
sented in the SF370 or MGAS5005 genomes, the sequence reads
were mapped to a GAS pseudopangenome constructed using
21 complete genomes representing 13 M-protein serotypes (see
Materials and Methods for detail and Fig. S2 for an example).
Nearly all strain-to-strain differences in gene content were as-
sociated with differences in MGE content (Fig. 3). The great
majority of strains causing disease since the mid-1980s had the
same MGE content as MGAS5005; that is, they contained pro-
phage 5005.1 encoding superantigen SpeA and prophages 5005.2
and 5005.3 encoding DNases Spd3 and streptococcal DNase D2,
(SdaD2), respectively. However, three other abundantly repre-
sented patterns of variation in prophage content and several less-
common variant patterns also were found (Fig. 3). A few rare-
variant MGE patterns indicated ICE acquisitions consistent with
sporadic reports of serotype M1 strains resistant to tetracycline
or macrolides (35).
Molecular Evolutionary Genetics of Contemporary M1 Clone Emergence.
In a model we put forth to explain the evolutionary genetic
events that resulted in an abundant postresurgent contemporary
clone of serotype M1 GAS (24), we hypothesized that an an-
cestral serotype M1 strain initially acquired phages encoding
speA and sdaD2. This organism subsequently experienced a hor-
izontal gene transfer event involving the acquisition of a 36-kb
chromosomal region encoding streptolysin O and NAD+-glyco-
hydrolase virulence factors. Near identity of this DNA sequence
with the corresponding region in the genomes of two serotype
M12 strains led us to hypothesize that a serotype M12 strain
served as the donor of this DNA segment (24). However, because
of inadequate strain sample size and a lack of sufficient full-
genome sequence data, we were unable to unambiguously define
the precise order of these critical molecular events. Others have
proposed alternative evolutionary scenarios based on analysis of
very few strains, many with uncertain provenance (36).
Our large genome sequence dataset permitted us to generate a
comprehensive M1 population genetic structure (Fig. 3), against
which the timing of key events of the different models could be
tested. The great majority (n = 165; 96%) of the SF370-like strains
were isolated before or in 1988, whereas all MGAS5005-like
organisms were isolated in or after 1988 (Fig. 4). The emergence
of MGAS5005-like strains corresponds with reports of increased
M1 GAS infection frequency and severity on different continents
(1–3, 5–20). We found that the ancestral SF370-like organisms
had either the speA1 or speA2 allele, whereas the descendant
MGAS5005-like strains have only the speA2 allele (Fig. 5). These
two alleles differ by a single nonsynonymous nucleotide substitu-
tion that results in a Gly110Ser amino acid replacement (37). This
amino acid residue is located immediately adjacent to a region of
SpeA-containing cysteine residues that participate in the formation
of a disulfide loop required for T-cell mitogenicity (38). Relative
to SpeA1, the SpeA2 variant has significantly higher affinity for
class II major histocompatibility complex-DQ molecules (39).
Analysis of the genome sequence data using assembly, com-
parison, and phylogenetic inference tools (EDENA, BLAST,
MOSAIK, and TABLET) revealed three critical points. First,
importantly, the entire 40-kb prophage encoding the speA2 allele
found in contemporary MGAS5005-like strains is virtually iden-
tical in nucleotide sequence to the speA1-encoding prophage
present in the SF370-like strains from the 1920s. Second, the
two prophages are integrated at the same chromosomal location
in SF370- or MGAS5005-like strains. Third, all speA-encoding
strains from the mid-1970s onward have the speA2 allele, a
finding confirmed by PCR amplification and targeted DNA se-
quencing. This discovery, along with the overall phylogeny of the
serotype M1 population, indicates that the speA2 allele evolved
from the speA1 allele in a single genetic event that occurred well
before the emergence of severe invasive infections and sub-
sequently became abundantly represented in contemporary M1
strains by clonal expansion (Fig. 5). Inasmuch as the speA2 allele
has never been found in strains other than contemporary M1
organisms (37, 40, 41), we conclude that identity-by-descent (verti-
cal) inheritance from a common precursor cell is the only reason-
able explanation for the abundant presence of speA2 among
contemporary M1 organisms.
Similar to the speA prophage findings, the spd3-containing
prophage present in old or contemporary strains is integrated at
the same chromosomal location and has a low level of poly-
morphism throughout its ∼33-kb sequence among the vast ma-
jority of all M1 strains present in the population from the early
1970s onward (Fig. 5). As with the speA-positive strains, the
phylogenetic structure of the 3,615 genomes indicates that ac-
quisition of the spd3-encoding prophage occurred well before the
resurgence in M1 invasive infection.
A key unresolved issue in the molecular evolutionary events
resulting in contemporary M1 strains is the timing of acquisition
of prophage 5005.3 encoding the SdaD2 DNase virulence factor.
Our analysis discovered that prophage 5005.3 was abundantly
present among the M1 strains isolated temporally (∼late 1960s)
before the speA2 allele evolved from speA1 (∼early 1970s; Fig. 5).
Thus, the phylogeny indicates that acquisition of prophage 5005.3
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Fig. 2. Genetic relationships among the 3,615 serotype M1 strains. Genetic
relationships among the strains were inferred by the method of neighbor
joining, using SplitsTree. Strains with an SF370-like 36-kb purA-to-nadC re-
gion are shown in blue, and strains that are MGAS5005-like (i.e., strains that
have a mosaic chromosome with a recombined M12-like purA-to-nadC re-
gion) are shown in red. (A) Genetic relationships inferred on the basis of all
13,221 core chromosomal SNPs identified among the 3,615 strains. Including
SNPs within the 36-kb purA-to-nadC region, the SF370-like strains are ge-
netically distinct from the MGAS5005-like strains. (B) Genetic relationships
inferred based on the 12,355 core chromosomal SNPs that remain after ex-
clusion of the horizontally acquired SNPs in the 36-kb purA-to-nadC region
of recombination. Exclusion of the SNPs in the 36-kb region of recombina-
tion collapses the vast majority of the genetic distance between the older
SF370-like progenitor strains and the contemporary MGAS5005-like descendant
strains. Excluding SNPs in the 36-kb purA-to-nadC region and rooting the tree
using GAS serotype M3 strain MGAS315 as an outgroup places SF370 and
older SF370-like strains on one side of the tree (upper left), and most SF370-
like strains from the ∼mid-1970s onward and all MGAS5005-like strains on
the opposite side (lower right). Both trees are shown at the same scale.
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encoding sdaD2 occurred before acquisition of prophage 5005.1
encoding speA. Importantly, analogous to prophages 5005.1 and
5005.2, regardless of the year of isolation, the 5005.3 prophage
had very little genetic diversity and was integrated at the same
chromosomal location. These findings also strongly argue for
a clonal expansion and identity-by-descent evolutionary pathway.
Finally, the core genome phylogeny, coupled with information
about the year of isolation of strains we studied (Fig. 5), un-
ambiguously shows that acquisition of the new 36-kb region of
recombination occurred after the phage-acquisition events de-
scribed earlier. Hence, we must conclude that in the evolutionary
path leading to the most recent common ancestor of contemporary
370.1, speC-spd1
370.2, speH-speI
370.3, spd3
370.4, ?
5005.1, speA2
5005.2, spd3
10750RD.2-like, ermB
10394.4-like, mefA
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Fig. 3. MGE content of MGAS5005-like M1 strains. Shown is the phylogeny inferred by neighbor-joining for 3,443 MGAS5005-like contemporary M1 strains
based on 12,355 concatenated core SNPs. SNPs located in the 36-kb region of recombination and the MGEs were excluded to constrain the inferred phylogeny
to vertically inherited SNPs. Labeled is the branch leading to the tree root and SF370-like strains, which are not shown because of space constraints. Strains are
colored by MGE content, as indicated in the bottom figure inset. There were 13 MGE content patterns found in 5 or more strains of the cohort. MGE patterns
found in 4 or fewer strains are shown collectively as open circles/triangles (n = 69). The vast majority of the strains (84%) have the same MGE content as strain
MGAS5005 (i.e., no difference in gene content was detected relative to MGAS5005). Invasive isolates are shown as circles, and pharyngitis isolates as triangles.
Evident in the tree are numerous independent occurrences of MGE acquisition and loss, as well as commonality in MGE content among strains as a conse-
quence of vertical inheritance. MGE content of the 172 SF370-like strains is shown in Fig. 5.
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epidemic M1 organisms, this horizontal gene transfer event was
the final major molecular event preceding their emergence and
explosive geographic dissemination.
The comprehensive M1 genomic population structure coupled
with the year of isolation data (i.e., the historic record) places the
36-kb purA–nadC recombination event as occurring after the
early 1970s, preceding isolation of the first MGAS5005-like
strains in the late 1980s. To more precisely determine the time of
occurrence of this 36-kb horizontal recombination event, a best-
fit rooted time-tree (a chronogram) was generated for all 3,443
MGAS5005-like strains, using Path-O-Gen. This analysis esti-
mated that the year of origin of the most recent common an-
cestor of MGAS5005-like strains was 1983 (Fig. 6).
To summarize, the relative lack of genetic diversification among
contemporary serotype M1 strains indicates that the precursor
clone arose recently and that its progeny spread intercontinentally
to many localities in an epidemic wave of pharyngitis and serious
invasive infections occurring over the last 25 y.
Temporal Dissemination of Subclones. Few genome-scale data sets
are available for comprehensive, population-based samples of
bacterial pathogens that bear on temporal dissemination patterns
and rates. Our study was designed to help alleviate this knowledge
deficit. Understanding the temporal and geographic dynamics of
pathogen transmission in the human population is relevant to many
aspects of basic, clinical, and translational research, including
molecular pathogenesis, vaccine development and deployment,
and public health. We studied geographically and temporally
diverse strain samples, most of which are population-based and
comprehensive. These strain sample features facilitate our ability
to test the hypothesis that temporal structure exists in clone dis-
tribution. Consistent with our hypothesis, strong patterns of tem-
poral structure were evident in the phylogeny (Fig. 7A). This was
readily apparent for individual geographic regions. For example,
all invasive strains in Finland recovered between 1988 and 2000
are present only in the upper of the two major trunks of the
contemporary M1 phylogenetic tree (Fig. 7B). In contrast, the
vast majority of strains from the 2003–2011 disease wave are
located in the lower trunk of the tree (Fig. 7B).
Population Genomics of Pharyngitis and Sterile-Site Strains. We
know relatively little about the molecular population genomic
relationship between bacterial strains of the same species causing
distinct types of infections. Our sample included 597 M1 phar-
yngitis strains from Finland, most of which were recovered in
a population-based surveillance study conducted between 1994
and 1997 (13), years for which we also had a comprehensive
country-wide sample of invasive strains (42). For most M protein
serotypes of GAS, including M1 strains, there is proportionally
a far larger number of pharyngitis cases compared with invasive
infections occurring in the same geographic area. On the basis of
core SNPs, we discovered that as a population, the pharyngitis
strains clustered phylogenetically, with invasive strains causing
disease during the same period in Finland (Fig. 8A). In addition,
the pharyngitis and invasive M1 strains contained the same
complement of toxin-encoding prophages (Fig. 3). Therefore,
the invasive and pharyngitis isolates are not distinct populations
based on either the core or dispensable genetic content. Rather,
they derive from a common genetic pool. We conclude that the
explanation most parsimonious with the phylogeny is that in-
vasive isolates evolve repeatedly from the population of strains
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Fig. 5. Timing of molecular genetic events leading to the emergence of the contemporary MGAS5005-like M1 strains. Illustrated is the phylogeny of 198
strains based on 1,594 concatenated core SNPs inferred by neighbor-joining. SNPs located in the 36-kb region of recombination and the MGEs were excluded
to constrain the inference to primarily vertically inherited SNPs. Shown as circles are all 172 strains with an SF370-like 36-kb region. Nearly all of these strains
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isolated in 1988 (n = 25), the first year such strains are present in the study sample. (A) Prophage content is illustrated for each strain by color, as shown in the
inset figure on the right. The majority of the strains (n = 134/198, 68%), including the majority (n = 50/81, 62%) of the SF370-like strains from the 1970s, have
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causing pharyngitis in the same period and geographic region.
This should not be interpreted to mean the pharyngitis and
invasive strains as populations are genetically identical, be-
cause they are not. For example, we found differences in allele
frequencies between these two populations in genes such as hasA
and hasB that are involved in hyaluronic acid capsule bio-
synthesis (Fig. 8B and Fig. S3). We also identified a high fre-
quency of occurrence of frameshift (inactivating) mutations in
the hasA gene in pharyngitis strains (Fig. 8B). These mutations
are known to down-regulate hyaluronic acid capsule expression
and result in increased virulence. A divergent signal of diver-
sifying selection between pharyngitis and invasive isolates was
also discovered in population genomic investigation of a limited
number of GAS serotype M3 strains (43).
Comparative Strain Virulence in Infected Nonhuman Primates. The
extensive reported clinical and epidemiologic data are consistent
with the idea that preresurgence serotype M1 strains recovered
before ∼1988 are less virulent than postresurgence strains causing
human infections after ∼1988 (1–3, 5–20). However, this idea has
not been rigorously tested. To directly test this hypothesis, we
used two nonhuman primate models of infection to compare the
virulence of preresurgence reference strain SF370 with post-
resurgence strain MGAS2221. The cynomolgus macaque has
been used extensively for experimental studies because it closely
approximates human–GAS molecular interactions (27, 44–46).
Two groups of monkeys were infected in the upper respiratory
tract with either strain SF370 or strainMGAS2221 andmonitored
for 21 d. Strain SF370 was used because it was the first GAS
genome to be sequenced, has been used extensively in studies
over the last 13 y, and contains the old variant of the 36-kb region
of recombination. Similarly, the genome of strain MGAS2221 has
been sequenced, and the strain has been used in a variety of ex-
perimental studies. Neither strain has function-altering mutations
in major regulatory genes such as covR, covS, ropB, or mga. We
discovered that strain MGAS2221 was significantly more virulent
in this pharyngitis infectionmodel, as assessed by bacterial burden
recovered over the course of the experiment (Fig. 9A).
We next tested the hypothesis that strain MGAS2221 was
significantly more virulent during invasive infection, as assessed
using a well-described nonhuman primate model of necrotizing
fasciitis (27, 44, 45). Significantly more bacteria were recovered
from animals infected with MGAS2221 compared with those
infected with strain SF370 (Fig. 9B), a finding that strongly
supports the enhanced-virulence hypothesis. In addition, strain
MGAS2221 caused significantly larger lesions and more severe
histopathology than strain SF370 (Fig. 9 C and D).
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Concluding Comment
In recent years, large-scale genome sequencing has been used to
address previously unapproachable problems in diverse areas
such as cancer genetics and human molecular evolution (47–50).
Although progress has been made with some pathogens (51–55),
relatively little analogous work has been performed to un-
derstand molecular factors underpinning strain emergence and
the comprehensive genomic landscape of bacterial epidemics.
Our study, the largest bacterial whole-genome sequencing pro-
ject reported thus far, was designed to provide knowledge about
these areas of infectious disease research. Specifically, we tested
the hypothesis that large-scale genome sequencing of population-
based strain samples, coupled with animal infection models, would
provide clarifying data bearing on heretofore vague molecular
events contributing to the evolutionary genetic events underpin-
ning epidemic disease.
Much theorizing and speculation and some data have been
presented in efforts to explain the precipitous increase in fre-
quency and severity of invasive infections caused by serotype M1
GAS during the mid-1980s (14, 24, 36, 56–60). Analyses using
techniques that index variation within a relatively small area of
the GAS chromosome or very small numbers of strains sup-
ported the idea that many contemporary M1 isolates were
clonally related (8, 24, 36, 40, 41, 56, 58, 59). These studies led to
several distinct hypotheses (24, 36, 60) to explain the molecular
genetic events underpinning the emergence of the contemporary
M1 clone. A key difference between models was the order of the
molecular events leading to now-extant contemporary serotype
M1 strains. Delineation of the nature and order of precise ge-
netic changes underlying strain emergence and altered virulence
is of particular importance, as it helps link cause and effect and
generate testable hypotheses. Moreover, previous studies did not
permit a detailed understanding of the genome-wide genetic
relationships among currently circulating M1 strains. In one model
(24), acquisition of the 36-kb region of recombination from an
M12 donor organism was the final event, whereas Maamary et al.
(36) concluded that acquisition of the SpeA-encoding prophage
was the triggering event. The present study permitted us to clearly
delineate the crucial evolutionary genetic pathway. The only rea-
sonable interpretation of the aggregate population genomic data
obtained from analysis of these 3,615 genomes from widespread
areas is that acquisition of the 36-kb region of recombination was
the final major genetic event preceding virulent clone emergence
and intercontinental spread. Thus, the claim (36) that horizontal
transfer of the M12-like 36-kb region was a relatively early event
preceding acquisition of the SpeA-encoding phage in the evolu-
tionary path of contemporary M1 strains is not supported by the
comprehensive population genomic structure and is wrong.
Our work permitted us to delineate the critical chain of mo-
lecular events that gave rise to the organisms causing the con-
temporary epidemic of serotype M1 GAS human infections. The
molecular events included phage-mediated virulence gene ac-
quisition, single nucleotide variant accumulation, and horizontal
transfer of the 36-kb region encoding the virulence factors Nga
and Slo (61–73), likely mediated by generalized transduction
(24). It is now clear from our analysis that a complex multistep
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molecular process occurring sequentially over decades culminated
in a single organism with increased virulence that fulminantly
disseminated globally and displaced other GASM1 lineages. The
genome analysis permitted us to estimate the acquisition of the
36-kb region encoding Nga and Slo to a horizontal gene transfer
and recombination event that occurred in 1983. In this regard, it
is important to note that infections caused by M1 strains clearly
increased significantly in frequency and severity in the United
States between 1980–1988 (16), and in the United Kingdom
between 1983 and 1985 (9). Moreover, it has been well docu-
mented (2, 3, 5, 7, 8, 11, 12, 14, 19) that epidemic M1 infections
occurred in Norway, Sweden, Finland, Denmark, Australia, and
Canada in the ensuing years. The result of the genetic events we
describe here was an explosive intercontinental epidemic of se-
rotype M1 human infections including pharyngitis and severe
invasive diseases such as necrotizing fasciitis, the “flesh-eating”
infection. GAS causes >600 million cases of human infections
yearly, and extensive epidemiologic studies have shown that se-
rotype M1 organisms are frequently the most abundant M pro-
tein serotype (3, 4, 7, 9, 14, 74–76). In conclusion, the molecular
evolutionary events transpiring in just one bacterial cell ulti-
mately produced many millions of human infections worldwide.
Our retrospective study analyzed strains stored in large
population-based repositories, in some cases over decades. The
availability of strain samples of this type was essential to the
success of our investigation. Given that it is possible to sequence
the genomes of thousands of bacterial strains, regardless of
species, in short order at an economically feasible cost, it is now
reasonable with appropriate sampling and epidemiologic strat-
egies to identify strain emergence and patterns of dissemination
in near-real-time. These types of studies, conducted in synchrony
with detailed analyses of relevant emergent phenotypic proper-
ties (e.g., virulence, antimicrobial agent resistance, dissemination
capacity), will undoubtedly provide new information useful for
significantly enhanced basic, clinical, and translational research
on human, veterinary, and plant pathogens. This approach will
permit identification of pathogenic clones during, rather than
after, emergence and widespread dissemination. In addition,
extensive full-genome analysis of many emerging or emerged
pathogens may give rise to generalizable mechanisms underlying
the evolutionary genomics of epidemics.
Materials and Methods
Bacterial Strain Samples. This investigation is based on 3,018 invasive and 597
pharyngitis serotype M1 strains that were recovered primarily from nine
distinct geographic regions on two continents (Table 1, Dataset S1, and Fig.
S1). Most strains were isolated between January 1994 and December 2012 as
part of comprehensive population-based surveillance studies in the time
frames shown in Fig. S1. The samples from Iceland and Finland were recovered
from 1988 through 2011. Strains from Georgia (metropolitan Atlanta area)
and Minnesota (statewide) were collected as part of the Active Bacterial
Core Surveillance Program administered by the Centers for Disease Control
and Prevention (www.cdc.gov/abcs/index.html). These two states were chosen
for study because they are geographically distant and because their census
population sizes approximate those of several of the Nordic countries in our
study. The sample also included a small number of strains of historic interest
from several other countries and times that have been described elsewhere
(24, 40, 41). Reference strain SF370 (23) was purchased from ATCC.
Whole-Genome Sequencing and Polymorphism Analysis. DNA extracted from
eachofthe3,615strainswaspreparedformultiplexedsequencing,using Illumina
Nextera XT kits (27). Genome sequence data were obtained predominantly
with an Illumina HiSeq2000 instrument according to the manufacturer’s
instructions. Most runs included 96 bar-coded sequencing libraries in each
of the eight lanes of a flowcell (i.e., 768 strains sequenced concurrently). A few
genomes were sequenced with an Illumina MiSeq instrument. Polymorphisms
(SNPs and indels) were identified relative to corrected reference serotype M1
strains MGAS5005 (GenBank accession number CP000017) and/or SF370
(GenBank accession number AE004092) (23, 24), using VAAL software and
methods described in SI Materials and Methods. The nature of the SNPs (coding/
noncoding, synonymous/nonsynonymous, etc.) was determined using SNPfx.pl
(a PERL script developed in-house). Sequence data for the 3,615 genomes have
been deposited in the National Center for Biotechnology Information (NCBI)
Sequence Read Archive (accession number SRA036051).
Gene Content and Mobile Genetic Element Analysis. The known GAS pan-
genome core and accessory gene content were determined on the basis of
21 complete GAS genomes of 13 emm types, using PanOCT and reciprocal
BLAST best-hit. A GAS pseudopangenome sequence (2.84 Mb, 3,167 genes)
was generated by concatenating all additional accessory genes onto the
MGAS5005 genome. Concatenated accessory genes included 50 bp of
flanking sequence to facilitate subsequent read mapping. Sequence reads
for all 3,615 serotype M1 strains were mapped to the GAS pseudopange-
nome using Mosaik (https://code.google.com/p/mosaik-aligner/), and gene
fragments per kilobase per million mapped reads (FPKM) values were de-
termined using Cufflinks. FPKM values relative to MGAS5005 were used to
make gene presence or absence calls and then to determine MGE content
for all 3,615 strains. Reads not aligning to the GAS pseudopangenome were
assembled de novo using EDENA (SI Materials and Methods), and resultant
contigs greater than 100 nucleotides were used to query the NCBI non-
redundant database, using BLAST. Additional bioinformatic analyses are
described in SI Materials and Methods.
Experimental Animal Infections. The virulence of strains SF370 and MGAS2221
was assessed in pharyngitis and necrotizing fasciitis models, using cyno-
molgus macaques (Macaca fasicularis) (Charles River BRF), as previously
described (44–46). Strains SF370 (n = 3 animals) or MGAS2221 (n = 4 animals)
were used. For the pharyngitis studies, animals were anesthetized, in-
oculated in the upper respiratory tract with 1 × 108 cfu, and sampled se-
quentially for 21 d. For the necrotizing fasciitis experiments, animals were
anesthetized and inoculated intramuscularly in the anterior thigh to a uni-
form depth with 1 × 108 cfu/kg of GAS. The animals were observed con-
tinuously for ∼24 h, euthanized, and necropsied. The study protocols were
approved by the Houston Methodist Research Institute Animal Care and
Use Committee.
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